Surgery News and Research

RSS

Breast cancer survivor supports patients and survivors of breast cancer

Barbara Feigin, successful business owner and breast cancer survivor, wanted to find a unique and memorable way to honor other breast cancer survivors and those who have fallen to the disease so she decided to paint the 44,000 square-foot administrative building at her company MainStreet America pink.

1 Oct 2014

Managing diabetes and intensive exercise: an interview with Dr Rafael Castol, Team Novo Nordisk

Team Novo Nordisk is a professional cycling team that races at UCI Pro Continental level. It's the first ever team to be made up of athletes diagnosed with Type 1 diabetes. The team was created three years ago, and is part of the Changing Diabetes initiative developed by Novo Nordisk.

From Novo Nordisk 1 Oct 2014

Bionic Vision Australia reports positive results of prototype implant in patients with RP-induced vision loss

Bionic Vision Australia (BVA), a consortium of researchers working together to develop bionic eye devices to restore a sense of vision to people with profound vision loss, today announced the successful completion of the first clinical trial of its prototype 24-channel percutaneous implant in patients with profound vision loss from the eye disease retinitis pigmentosa (RP).

1 Oct 2014

Sanofi, Regeneron report positive Phase 2 study of dupilumab in patients with CSwNP

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced that a Phase 2a proof-of-concept study of dupilumab, an investigational therapy that blocks IL-4 and IL-13 signaling, met all primary and secondary endpoints in patients with moderate-to-severe chronic sinusitis with nasal polyps (CSwNP) who did not respond to intranasal corticosteroids.

30 Sep 2014

More insurers change how they pay medical providers

Commercial insurers are moving rapidly from the old system of paying health providers for every test or procedure they do toward payments based on the value rather than volume of services, according to a report by Catalyst for Payment Reform, a business coalition focused on health care costs.

30 Sep 2014

PD-L1 protein could be a potential immunotherapy target for malignant pleural mesothelioma

Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to data from a prospective randomized phase II trial presented at ESMO 2014 Congress in Madrid.

30 Sep 2014

Bausch + Lomb’s sub-micron loteprednol etabonate ophthalmic gel meets primary endpoint

Bausch + Lomb, a wholly owned subsidiary of Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX), today announced that its next generation sub-micron gel formulation of loteprednol etabonate was statistically superior to placebo (vehicle gel) in eliminating inflammation and pain following cataract surgery by study day eight, the primary endpoints in the first Phase 3, multi-center, double-masked, vehicle-controlled, parallel-group study.

30 Sep 2014

Aspen Dental expands operations with a new dental office in Hermitage, Tennessee

A new Aspen Dental office is opening in Hermitage, TN on Thursday, October 2. Located at 4054 Lebanon Pike, the conveniently located practice will provide dental services that range from implant services and dentures to general dentistry and restoration.

30 Sep 2014

Specific nurse-to-patient staffing standards lower job-related injuries, illnesses for nurses

A 2004 California law mandating specific nurse-to-patient staffing standards in acute care hospitals significantly lowered job-related injuries and illnesses for both registered nurses and licensed practical nurses, according to UC Davis research published online in the International Archives of Occupational and Environmental Health.

30 Sep 2014

New Aspen Dental office opened in Sebring, Florida

A new Aspen Dental office is opening in Sebring, FL on Thursday, October 2. Located at 1855 US 27 North, the conveniently located practice will provide dental services that range from dentures and preventive care to general dentistry and restoration.

30 Sep 2014

Occlutech's Paravalvular Leak Closure Device European CE Mark approval

Occlutech, a leading innovator of products to treat structural heart disease today announced that it has obtained a European CE Mark approval for its dedicated Paravalvular Leak Closure Device, (PLD).

29 Sep 2014

Increasing prevalence of obstructive sleep apnea threatens public health and safety

Public health and safety are threatened by the increasing prevalence of obstructive sleep apnea, which now afflicts at least 25 million adults in the U.S., according to the National Healthy Sleep Awareness Project. Several new studies highlight the destructive nature of obstructive sleep apnea, a chronic disease that increases the risk of high blood pressure, heart disease, Type 2 diabetes, stroke and depression.

29 Sep 2014

OSU engineers develop simple device to improve hand function after surgery

Engineers at Oregon State University have developed and successfully demonstrated the value of a simple pulley mechanism to improve hand function after surgery.

29 Sep 2014

Cediranib combined with chemotherapy improves survival in recurrent cervical cancer

For patients with cervical cancer that has recurred after treatment or has spread elsewhere in the body, adding the experimental drug cediranib to standard chemotherapy improves tumour shrinkage and adds a modest improvement in progression-free survival, researchers report at the ESMO 2014 Congress in Madrid.

29 Sep 2014

Myriad Genetics' Tumor BRACAnalysis CDx identifies 44% more candidates for PARP therapy

Myriad Genetics, Inc. today announced that its Tumor BRACAnalysis CDx- companion diagnostic test significantly improved the detection of cancer-causing BRCA1/2 mutations by 44 percent in women with ovarian cancer. Data from this new study were presented at the 2014 European Society for Medical Oncology annual meeting in Madrid, Spain.

29 Sep 2014

EnteroMedics' CE Mark for Maestro System expanded to include management of Type 2 diabetes mellitus

EnteroMedics Inc., the developer of medical devices using neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders, today announced that its CE Mark for the Maestro Rechargeable (RC) System for obesity was expanded to include the management of Type 2 diabetes mellitus through improved glycemic control.

29 Sep 2014

SARMS tool assesses development of robotic microsurgery skills

A new standardized assessment provides a useful tool for tracking surgeons' progress as they develop the skills needed to perform robot-assisted microsurgery, reports a study in the October issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

29 Sep 2014

Decision analysis techniques can help women sort through breast reconstruction options

Decision analysis techniques can help surgeons and patients evaluate alternatives for breast reconstruction-leading to a "good decision" that reflects the woman's preferences and values, according to an article in the October issue of Plastic and Reconstructive Surgery, the official medical journal of the American Society of Plastic Surgeons (ASPS).

29 Sep 2014

AAPA welcomes NGA’s report that highlights role of PAs in the U.S. healthcare

The American Academy of Physician Assistants welcomes a new report from the National Governors Association (NGA) that highlights the important—and rapidly growing—role of physician assistants (PAs) in the U.S. healthcare workforce.

27 Sep 2014

Yale researchers find that not all obese people feel better after bariatric surgery

Most severely obese people experience much better spirits once they shed weight through a diet, lifestyle changes or medical intervention. This is unfortunately not true for everyone, says Valentina Ivezaj and Carlos Grilo of the Yale University School of Medicine in the US. In an article in Springer's journal Obesity Surgery, the researchers advise that the levels of depression in patients be measured six to 12 months after they have had such bariatric surgery.

27 Sep 2014

Surgery News and Research

Breast cancer survivor supports patients and survivors of breast cancer

Managing diabetes and intensive exercise: an interview with Dr Rafael Castol, Team Novo Nordisk

Bionic Vision Australia reports positive results of prototype implant in patients with RP-induced vision loss

Sanofi, Regeneron report positive Phase 2 study of dupilumab in patients with CSwNP

More insurers change how they pay medical providers

PD-L1 protein could be a potential immunotherapy target for malignant pleural mesothelioma

Bausch + Lomb’s sub-micron loteprednol etabonate ophthalmic gel meets primary endpoint

Aspen Dental expands operations with a new dental office in Hermitage, Tennessee

Specific nurse-to-patient staffing standards lower job-related injuries, illnesses for nurses

New Aspen Dental office opened in Sebring, Florida

Occlutech's Paravalvular Leak Closure Device European CE Mark approval

Increasing prevalence of obstructive sleep apnea threatens public health and safety

OSU engineers develop simple device to improve hand function after surgery

Cediranib combined with chemotherapy improves survival in recurrent cervical cancer

Myriad Genetics' Tumor BRACAnalysis CDx identifies 44% more candidates for PARP therapy

EnteroMedics' CE Mark for Maestro System expanded to include management of Type 2 diabetes mellitus

SARMS tool assesses development of robotic microsurgery skills

Decision analysis techniques can help women sort through breast reconstruction options

AAPA welcomes NGA’s report that highlights role of PAs in the U.S. healthcare

Yale researchers find that not all obese people feel better after bariatric surgery

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News